Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial (Q46223001)
Jump to navigation
Jump to search
scientific article published on 29 November 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial |
scientific article published on 29 November 2008 |
Statements
1 reference
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial (English)
1 reference
1 reference
Roberto Bernabei
1 reference
Roger Bullock
1 reference
Alfonso J Cruz Jentoft
1 reference
Lutz Frölich
1 reference
Christoph Hock
1 reference
Minna Raivio
1 reference
Eric Triau
1 reference
Maurits Vandewoude
1 reference
Anders Wimo
1 reference
Elizabeth Came
1 reference
Bart Van Baelen
1 reference
Gerry L Hammond
1 reference
Joop C van Oene
1 reference
Susanne Schwalen
1 reference
29 November 2008
1 reference
1 reference
8
1 reference
1
1 reference
39-47
1 reference
Identifiers
1 reference
1 reference